Amazing faculty of #TXMPN22 ⁦Naveen Pemmaraju, MD⁩ #SergeVerstovsek ⁦Stephen Oh⁩ ⁦Andrew Kuykendall MD⁩ ⁦Raajit Rampal, M.D.Ph.D.⁩ ⁦Eric Padron MD⁩ ⁦Abdulraheem Yacoub⁩ ⁦Jeanne M Palmer⁩ ⁦Nicole Kucine, MD,MS⁩ ⁦Prithviraj Bose⁩ ⁩ ⁦UT Health San Antonio MD Anderson⁩ ⁦⁦MPN Research Foundation⁩

Ok, done. Thanks to S Faiz , #SergeVerstovsek & Cezar Iliescu for their support. In summary, I don’t want you to fall 😴 we found that pts with myelofibrosis had lower incidence of Group V PH & more of Group II PH. Seems that diastolic parameters & NT ProBNP predicted death

In person & virtual= the best experience with the MPN experts at #TXMPN22 . Prithviraj Bose Aaron Gerds MD, MS Ruben A. Mesa, MD Claire Harrison #SergeVerstovsek 👏👏

My great friend #MPNWarrior & legend #SergeVerstovsek at #EHA23 looking stylish, relaxed, and ready to defeat #myelofibrosis in his new role as #CMO of ⁦Kartos Therapeutics⁩ !! ⁦Naveen Pemmaraju, MD⁩ ⁦Prithviraj Bose⁩ ⁦Lucia Masarova, MD⁩ ⁦J.J. Kiladjian⁩ ⁦ #mpnsm ⁦

Honored to give the first talk at 4th MPN Asia meeting in Korea about treatment goals in #MPNSM and looking forward for great talks and discussion with outstanding faculty Ruben A. Mesa, MD #RichardSilver #SergeVerstovsek 小松則夫 研究室（順天堂大学血液内科学） #RobertKralovics

#SOHO22 | Backstage in the Speaker Ready Room/Green Room for our epic #SOHO22 #MPNSM session today, chaired by Jeanne M Palmer & Dr Harris Ali : L—>R: Prithviraj Bose Abdulraheem Yacoub Naveen Pemmaraju, MD & #SergeVerstovsek | #MPNSM Society of Hematologic Oncology (SOHO)

MPN Oral session off and running at #EHA22 presented by good friend and #MPNLegend #SergeVerstovsek ⁦MD Anderson Cancer Center⁩ ! Momelotinib superior to Danazol for MF in 2L for symptoms, anemia and splenomegaly ⁦European Hematology Association⁩ ⁦UT Health San Antonio MD Anderson⁩ ⁦Claire Harrison⁩

Amazing final day of MPN Spring Symposium! Great focus on MPN and Quality of Life #MPNSM . Wonderful faculty J.J. Kiladjian #SergeVerstovsek Jyoti Nangalia very well conceived and organized Peter Loffelhardt ! UT Health San Antonio MD Anderson

#ASCO23 🙌 Epic #MPNSM reunion ➡️ Discussing together the future of MPN field moving beyond JAK inhibitors from two of the original co-founders of the modern targeted era !! 👉 New Directions & Novel Agents & Combinations 💡 Ruben A. Mesa, MD Naveen Pemmaraju, MD #SergeVerstovsek | Claire Harrison

#ASH22 | Dr Lucia Masarova Lucia Masarova, MD will present our group’s long-term results of pegylated #interferon in patients with ET & PV with median f/u now of *15 years* | #MPNSM ash.confex.com/ash/2022/webpr… | #SergeVerstovsek MD Anderson Cancer Center #endcancer ASH

Check out the final results of our IST of sotatercept for anemia of MF published in Haematologica: 55 patients, RR around 30% both alone and with rux MD Anderson Cancer Center Bristol Myers Squibb Hagop Kantarjian,MD #sergeverstovsek #MPNSM
doi.org/10.3324/haemat…

As we look forward to potential new drug approvals in 2022 for MF, check out our review on momelotinib just out in J Hematol Oncol #mpnsm #sergeverstovsek ⁦MD Anderson Cancer Center⁩ pubmed.ncbi.nlm.nih.gov/35045875/

👉👉👉Our group’s new paper just out in PubMed ➡️ Thrombotic events & mortality risk in patients with newly diagnosed PV or ET - ⁦ScienceDirect⁩ | ⁦Naveen Pemmaraju, MD⁩ ⁦Aaron Gerds MD, MS⁩ ⁦Robyn M. Scherber MD⁩ #SergeVerstovsek | #MPNSM #endcancer sciencedirect.com/science/articl…

Our new review article 📢 Ten years after ruxolitinib approval for myelofibrosis: a review of clinical efficacy | ⁦Naveen Pemmaraju, MD⁩ ⁦Prithviraj Bose⁩ ⁦Raajit Rampal, M.D.Ph.D.⁩ ⁦Aaron Gerds MD, MS⁩ ⁦Angela Fleischman⁩ #SergeVerstovsek || #MPNSM tandfonline.com/doi/full/10.10…

Thanks to excellent colleagues Naveen Pemmaraju, MD Prithviraj Bose #SergeVerstovsek & the best place Hagop Kantarjian,MD MD Anderson Cancer Center to improve outcome of #mpnsm patients👍

Huge congratulations my friend #SergeVerstovsek on your well earned retirement and exciting next step in your journey to cure #MPNs MPN Research Foundation MPN_Hub Global MPN Scientific Foundation MPNAdvocatesNetwork MPN Ad&Ed Int'l Harry Gill, MD FRCP FRCPath Claire Harrison J.J. Kiladjian Aaron Gerds MD, MS Stephen Oh MD Anderson Cancer Center Angela Fleischman MPNCo&D Congress

Check out our latest review in Cancers on MF phenotypes ncbi.nlm.nih.gov/pmc/articles/P… MD Anderson Cancer Center Prithviraj Bose #sergeverstovsek

Pankit Vachhani Gaby Hobbs Aaron Gerds MD, MS Andrew Kuykendall MD Ruben A. Mesa, MD Lucia Masarova, MD Raajit Rampal, M.D.Ph.D. Jeanne M Palmer Abdulraheem Yacoub #johnmascarenhas #sergeverstovsek

'Disease Modification' in Myelofibrosis: An Elusive Goal?
BMF or VAF reduction? Cytokine modulation? Any of these? What ultimately matters most? Grateful to Journal of Clinical Oncology for allowing us to share our thoughts Prithviraj Bose Pankit Vachhani MD Anderson Cancer Center #MPNSM #SergeVerstovsek

👉👉👉Delighted to share our new collaborative paper ➡️ hot off the press 📣 10 years after Ruxolitinib approval for Myelofibrosis: a review of clinical efficacy | Naveen Pemmaraju, MD Prithviraj Bose Raajit Rampal, M.D.Ph.D. Aaron Gerds MD, MS Angela Fleischman #SergeVerstovsek || #MPNSM

tandfonline.com/doi/full/10.10…